Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

258 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
CT angiography-based radiomics as a tool for carotid plaque characterization: a pilot study.
Cilla S, Macchia G, Lenkowicz J, Tran EH, Pierro A, Petrella L, Fanelli M, Sardu C, Re A, Boldrini L, Indovina L, De Filippo CM, Caradonna E, Deodato F, Massetti M, Valentini V, Modugno P. Cilla S, et al. Among authors: sardu c. Radiol Med. 2022 Jul;127(7):743-753. doi: 10.1007/s11547-022-01505-5. Epub 2022 Jun 9. Radiol Med. 2022. PMID: 35680773
Atherosclerotic Plaque Fissuration and Clinical Outcomes in Pre-Diabetics vs. Normoglycemics Patients Affected by Asymptomatic Significant Carotid Artery Stenosis at 2 Years of Follow-Up: Role of microRNAs Modulation: The ATIMIR Study.
Sardu C, Modugno P, Castellano G, Scisciola L, Barbieri M, Petrella L, Fanelli M, Macchia G, Caradonna E, Massetti M, Paolisso G, Marfella R. Sardu C, et al. Biomedicines. 2021 Apr 8;9(4):401. doi: 10.3390/biomedicines9040401. Biomedicines. 2021. PMID: 33917851 Free PMC article.
Sodium-glucose co-transporter2 expression and inflammatory activity in diabetic atherosclerotic plaques: Effects of sodium-glucose co-transporter2 inhibitor treatment.
D'Onofrio N, Sardu C, Trotta MC, Scisciola L, Turriziani F, Ferraraccio F, Panarese I, Petrella L, Fanelli M, Modugno P, Massetti M, Marfella LV, Sasso FC, Rizzo MR, Barbieri M, Furbatto F, Minicucci F, Mauro C, Federici M, Balestrieri ML, Paolisso G, Marfella R. D'Onofrio N, et al. Among authors: sardu c. Mol Metab. 2021 Dec;54:101337. doi: 10.1016/j.molmet.2021.101337. Epub 2021 Sep 7. Mol Metab. 2021. PMID: 34500107 Free PMC article.
Evidence of an anti-inflammatory effect of PCSK9 inhibitors within the human atherosclerotic plaque.
Marfella R, Prattichizzo F, Sardu C, Paolisso P, D'Onofrio N, Scisciola L, La Grotta R, Frigé C, Ferraraccio F, Panarese I, Fanelli M, Modugno P, Calafiore AM, Melchionna M, Sasso FC, Furbatto F, D'Andrea D, Siniscalchi M, Mauro C, Cesaro A, Calabrò P, Santulli G, Balestrieri ML, Barbato E, Ceriello A, Paolisso G. Marfella R, et al. Among authors: sardu c. Atherosclerosis. 2023 Aug;378:117180. doi: 10.1016/j.atherosclerosis.2023.06.971. Epub 2023 Jun 29. Atherosclerosis. 2023. PMID: 37422356
Effects of Sodium-Glucose Transporter 2 Inhibitors (SGLT2-I) in Patients With Ischemic Heart Disease (IHD) Treated by Coronary Artery Bypass Grafting via MiECC: Inflammatory Burden, and Clinical Outcomes at 5 Years of Follow-Up.
Sardu C, Massetti M, Testa N, Martino LD, Castellano G, Turriziani F, Sasso FC, Torella M, De Feo M, Santulli G, Paolisso G, Marfella R. Sardu C, et al. Front Pharmacol. 2021 Nov 15;12:777083. doi: 10.3389/fphar.2021.777083. eCollection 2021. Front Pharmacol. 2021. PMID: 34867407 Free PMC article.
Angiotensin receptor/Neprilysin inhibitor effects in CRTd non-responders: From epigenetic to clinical beside.
Sardu C, Massetti M, Scisciola L, Trotta MC, Santamaria M, Volpicelli M, Ducceschi V, Signoriello G, D'Onofrio N, Marfella L, Casolaro F, Amico MD', Ruocco A, Balestrieri ML, Mauro C, Rafaniello C, Capuano A, Paolisso G, Marfella R. Sardu C, et al. Pharmacol Res. 2022 Aug;182:106303. doi: 10.1016/j.phrs.2022.106303. Epub 2022 Jun 10. Pharmacol Res. 2022. PMID: 35697289 Free article.
Microplastics and Nanoplastics in Atheromas and Cardiovascular Events.
Marfella R, Prattichizzo F, Sardu C, Fulgenzi G, Graciotti L, Spadoni T, D'Onofrio N, Scisciola L, La Grotta R, Frigé C, Pellegrini V, Municinò M, Siniscalchi M, Spinetti F, Vigliotti G, Vecchione C, Carrizzo A, Accarino G, Squillante A, Spaziano G, Mirra D, Esposito R, Altieri S, Falco G, Fenti A, Galoppo S, Canzano S, Sasso FC, Matacchione G, Olivieri F, Ferraraccio F, Panarese I, Paolisso P, Barbato E, Lubritto C, Balestrieri ML, Mauro C, Caballero AE, Rajagopalan S, Ceriello A, D'Agostino B, Iovino P, Paolisso G. Marfella R, et al. Among authors: sardu c. N Engl J Med. 2024 Mar 7;390(10):900-910. doi: 10.1056/NEJMoa2309822. N Engl J Med. 2024. PMID: 38446676 Free PMC article.
Intra-plaque vascularization assessed in contrast-enhanced ultrasound predicts cardiovascular events in type 2 diabetes with no significant carotid atherosclerotic stenosis: a prospective study with therapeutic implications for SGLT2 inhibitor use.
Marfella R, Marfella LV, Fumagalli C, Rinaldi L, Sasso FC, Cozzolino D, Nappo F, Sellitto A, Romano C, Carusone C, Diodato G, Russo P, Marfella L, Tarantino NM, Carpinella G, Furbatto F, Gentile S, Guarino G, Satta E, Bellis A, Marinelli L, Donisi I, D'Onofrio N, Mauro C, Cappabianca S, Balestrieri ML, Sardu C. Marfella R, et al. Among authors: sardu c. Eur Heart J Imaging Methods Pract. 2025 Oct 23;3(4):qyaf129. doi: 10.1093/ehjimp/qyaf129. eCollection 2025 Oct. Eur Heart J Imaging Methods Pract. 2025. PMID: 41268052 Free PMC article.
SGLT2-inhibitors effects on the coronary fibrous cap thickness and MACEs in diabetic patients with inducible myocardial ischemia and multi vessels non-obstructive coronary artery stenosis.
Sardu C, Trotta MC, Sasso FC, Sacra C, Carpinella G, Mauro C, Minicucci F, Calabrò P, D' Amico M, D' Ascenzo F, De Filippo O, Iannaccone M, Pizzi C, Paolisso G, Marfella R. Sardu C, et al. Cardiovasc Diabetol. 2023 Apr 1;22(1):80. doi: 10.1186/s12933-023-01814-7. Cardiovasc Diabetol. 2023. PMID: 37005586 Free PMC article.
258 results